» Articles » PMID: 11287577

Muscle-specific Overexpression of the Adenovirus Primary Receptor CAR Overcomes Low Efficiency of Gene Transfer to Mature Skeletal Muscle

Overview
Journal J Virol
Date 2001 Apr 5
PMID 11287577
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Significant levels of adenovirus (Ad)-mediated gene transfer occur only in immature muscle or in regenerating muscle, indicating that a developmentally regulated event plays a major role in limiting transgene expression in mature skeletal muscle. We have previously shown that in developing mouse muscle, expression of the primary Ad receptor CAR is severely downregulated during muscle maturation. To evaluate how global expression of CAR throughout muscle affects Ad vector (AdV)-mediated gene transfer into mature skeletal muscle, we produced transgenic mice that express the CAR cDNA under the control of the muscle-specific creatine kinase promoter. Five-month-old transgenic mice were compared to their nontransgenic littermates for their susceptibility to AdV transduction. In CAR transgenics that had been injected in the tibialis anterior muscle with AdVCMVlacZ, increased gene transfer was demonstrated by the increase in the number of transduced muscle fibers (433 +/- 121 in transgenic mice versus 8 +/- 4 in nontransgenic littermates) as well as the 25-fold increase in overall beta-galactosidase activity. Even when the reporter gene was driven by a more efficient promoter (the cytomegalovirus enhancer-chicken beta-actin gene promoter), differential transducibility was still evident (893 +/- 149 versus 153 +/- 30 fibers; P < 0.001). Furthermore, a fivefold decrease in the titer of injected AdV still resulted in significant transduction of muscle (253 +/- 130 versus 14 +/- 4 fibers). The dramatic enhancement in AdV-mediated gene transfer to mature skeletal muscle that is observed in the CAR transgenics indicates that prior modulation of the level of CAR expression can overcome the poor AdV transducibility of mature skeletal muscle and significant transduction can be obtained at low titers of AdV.

Citing Articles

Delivery challenges for CRISPR-Cas9 genome editing for Duchenne muscular dystrophy.

Padmaswari M, Agrawal S, Jia M, Ivy A, Maxenberger D, Burcham L Biophys Rev (Melville). 2023; 4(1):011307.

PMID: 36864908 PMC: 9969352. DOI: 10.1063/5.0131452.


Intramuscular Delivery of Gene Therapy for Targeting the Nervous System.

Tosolini A, Sleigh J Front Mol Neurosci. 2020; 13:129.

PMID: 32765219 PMC: 7379875. DOI: 10.3389/fnmol.2020.00129.


Increasing myosin light chain 3f (MLC3f) protects against a decline in contractile velocity.

Kim J, Graber T, Liu H, Asakura A, Thompson L PLoS One. 2019; 14(4):e0214982.

PMID: 30964931 PMC: 6456215. DOI: 10.1371/journal.pone.0214982.


Adenovirus transduction: More complicated than receptor expression.

Sharma P, Martis P, Excoffon K Virology. 2017; 502:144-151.

PMID: 28049062 PMC: 5276731. DOI: 10.1016/j.virol.2016.12.020.


Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons.

Tosolini A, Morris R Sci Rep. 2016; 6:33058.

PMID: 27619631 PMC: 5020496. DOI: 10.1038/srep33058.


References
1.
Greber U, Willetts M, Webster P, Helenius A . Stepwise dismantling of adenovirus 2 during entry into cells. Cell. 1993; 75(3):477-86. DOI: 10.1016/0092-8674(93)90382-z. View

2.
Wickham T, Mathias P, Cheresh D, Nemerow G . Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993; 73(2):309-19. DOI: 10.1016/0092-8674(93)90231-e. View

3.
Mathias P, Wickham T, Moore M, Nemerow G . Multiple adenovirus serotypes use alpha v integrins for infection. J Virol. 1994; 68(10):6811-4. PMC: 237109. DOI: 10.1128/JVI.68.10.6811-6814.1994. View

4.
Acsadi G, Jani A, Huard J, Blaschuk K, Massie B, Holland P . Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1994; 1(5):338-40. View

5.
Elfenbein D, Alvira M, Buttrick P, Leinwand L . The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1994; 1(6):395-402. View